The pilot program in the field of pharmacist services regarding reproductive health is the Ministry of Health's response to President Andrzej Duda's veto of the amendment to the pharmaceutical law, which was to facilitate access to the so-called emergency contraception. This article is an attempt to evaluate the new regulations and discusses interpretation difficulties arising during the work on the new regulations. The study aims to resolve the legal nature of the procedures described in the regulation.
No takes yet. Share an insight, caveat, or question.
Wojciech Rożdżeński (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: